Serigen key facts
- Developer of biomedical products designed to provide bioabsorbable implants for soft and hard tissue repair.
- It has raised $1.2M; the latest was Later Stage VC ($120K) in Aug 2024.
- Notable investors include Indian Angel Network, BIRAC, Venture Center, IKP EDEN, Indian Department of Science and Technology — 16 tracked in total.
- Status: Privately Held (backing).
Who backs Serigen
16+- ·The complete investor list: 16 names
- ·Watch Serigen: the Monday email on marks, rounds and moves
Serigen funding rounds
No funding rounds for Serigen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Serigen investors
16 investors are on record for Serigen, including Indian Angel Network, BIRAC, Venture Center and IKP EDEN.
About Serigen
Developer of biomedical products designed to provide bioabsorbable implants for soft and hard tissue repair. The company's products are for human bone defects like bony voids, long bone defects, and traumatic and surgical osseous defects, enabling consumers to utilize osteoconductive bone graft substitutes based on silk fibroin material, a non-adherent wound dressing.
- Sector
- Healthcare
- HQ
- Pune, India
- Founded
- 2015
- Employees
- 35
- Website
- serigenmed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Serigen doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.